Metabolic Medications and Youth Hospitalizations for Asthma
Our findings show that the odds of severe asthma excerbations are substantially lower after the initiation of metabolic pharmacotheraphy, highlighting the positive impact that treatment of metabolic syndromes could have in reducing the risk of severe asthma exacerbations. This underscores the interconnectedness of metabolic and respiratory health and the need for further research into effective treatment strategies for individuals with asthma and obesity-related metabolic conditions.
Authors
- Arthur H. Owora (ORCID: https://orcid.org/0000-0002-4580-7428)
- Erick Forno (ORCID: https://orcid.org/0000-0001-6497-9885)
- Sixtus Aguree (ORCID: https://orcid.org/0000-0002-2374-4462)
- Yash Shah (ORCID: https://orcid.org/0009-0009-0272-8912)
- Bowen Jiang (ORCID: https://orcid.org/0000-0002-7386-290X)
Institutions
- Regenstrief Institute (US)
- Riley Hospital for Children (US)
- Indiana University Bloomington (US)
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- CHEST Pulmonary
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1016/j.chpulm.2025.100185
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Indiana University Health
- Riley Children's Foundation
- National Institutes of Health
- Agency for Healthcare Research and Quality
- School of Medicine, Indiana University
- National Heart, Lung, and Blood Institute